PitchBook News - Tricks of the carbon offsets trade

Read online | Don't want to receive these emails? Manage your subscription.

Log in

The Daily Pitch: VC

December 23, 2022

The Daily Pitch is powered by PitchBook’s industry-defining research and best-in-class data

In today's Daily Pitch, you'll find:

Learn about the opportunities and limitations associated with carbon offset trading platforms in our latest Emerging Space Brief.

We spoke with a former LP executive about the impact investing strategy at his recently launched firm, The Copia Group.

Chart of the day: Share of M&A deal value by payment type, from our Global M&A Report.

Today's Top Stories

Building a grand bazaar for carbon offsets

As corporations pursue net-zero commitments, many find that they cannot directly avoid their own emissions. Enter carbon offsets, which allow organizations to buy and sell credits that avoid, reduce or remove carbon emissions.

This market corollary to government mandates is generating an opportunity for carbon offset trading platforms. Our latest Emerging Space Brief lays out the landscape for these marketplaces with an eye toward the technology opportunities, limitations and outlook for the segment.

read the report

Share:

Quiz: Did you follow private markets in 2022?

(Jenna O'Malley/PitchBook News)

2022 brought drama galore to the private investment landscape.

The fallout from the war in Ukraine seemed to touch everything—even a Premier League buyout and a European startup competition. Disgraced founders were by turns arrested, sentenced and redeemed. Private equity expanded into blockchain funds and startup loans.

Our quiz has the highlights, the lowlights and everything in between.

take the quiz

Share:

Q&A: Ex-Northern Trust leader talks impact investing at new firm

Thomas

We caught up with Shundrawn Thomas, founder and managing partner at The Copia Group and former president of Northern Trust Asset Management, to talk about his firm, which he launched in September alongside partner Anthony Hoye.

The firm uses "nondilutive" strategies—typically in the form of credit solutions—to take a minority stake in portfolio companies and grow their value. For Thomas, Copia's investment thesis is equally strategic and philosophical: "We want to be able to partner with businesses that are truly scalable but also are mission-oriented," he said.

Recommended Reads

How the world's increasing dependence on a small handful of crops leaves us vulnerable to war, extreme weather and market turbulence. [Bloomberg]

Charting the world's top 10 most innovative countries over the last 12 years. [Visual Capitalist]

Have electric vehicles finally outgrown Tesla? Here are some important milestones the industry hit in 2022. [Vox]

Since yesterday, the PitchBook Platform added:

32

VC valuations

1766

People

573

Companies

21

Funds

See what our data software can do

Quick Takes

	The Daily Benchmark
	2016 Vintage Global Secondaries Funds
	VC Deals
	Aspen Neuroscience gets $40M in debt
	Gynger raises $21.7M in debt and equity
	Nectar Life Sciences secures $16.5M for allergy care
	Automotus nabs $9M in seed funding
	DarwinAI picks up $6M

The Daily Benchmark

2016 Vintage Global Secondaries Funds

Median IRR

21.22%

Top Quartile IRR

31.77%

1.72x

Median TVPI

Select top performers

Industry Ventures Special Opportunities Fund III

Timber Bay Fund I

Industry Ventures Secondary VIII

*IRR: net of fees

28 Funds in Benchmark »

Check out the latest version of PitchBook Benchmarks

VC Deals

Aspen Neuroscience gets $40M in debt

Biotech startup Aspen Neuroscience has received a $40 million loan from Silicon Valley Bank. The San Diego-based company closed a $147.5 million Series B earlier this year. Aspen creates cell therapies to treat neurological diseases like Parkinson's disease.

View round

View 54 competitors »

Gynger raises $21.7M in debt and equity

Software financing startup Gynger has launched from stealth, raising $11.7 million in seed funding and $10 million in debt financing. Upper90 and Switzerland's Vine Ventures led the seed round with Gradient Ventures, Alphabet's AI-focused venture firm, also participating. Upper90 is providing the debt financing.

View round

View similar company »

Nectar Life Sciences secures $16.5M for allergy care

Nectar Life Sciences, a startup that offers an allergy care platform, has closed a $16.5 million Series A. Harmony Partners led the round with participation from Juxtapose and Obvious Ventures.

View round

View similar company »

Automotus nabs $9M in seed funding

Automotus has closed a $9 million seed round led by investors including Quake Capital, Bridge Investments and Los Angeles Cleantech Incubator, TechCrunch reported. The company's software helps cities manage parking, deliveries and curbside safety.

View round

View 4 competitors »

DarwinAI picks up $6M

BDC Capital has led a $6 million round in AI manufacturing startup DarwinAI. The company has received previous funding from investors including Honeywell Ventures, Obvious Ventures and Inovia Capital.

View round

View 34 competitors »

Chart of the Day

Source: PitchBook's Q3 2022 Global M&A Report

About PitchBook | Terms of use | Advertise with us | Contact

This email was sent to you via the PitchBook Platform.

Do you want to change your email address, get a different edition or unsubscribe? Manage your subscription here.

PitchBook News - Tricks of the carbon offsets trade

Older messages

Unwrapping outlooks on tech for 2023

A chance of sun in Europe's 2023

Analysts predict tough 2023 for PE

Forecasting a cloudy 2023 for VC

Fusion fantasy, solar substance

You Might Also Like

🔍 How Smashd Added 500K+ Followers W/ One Content Series

The Biggest ClickBank Event of the Year - Are You Ready?

Full HCU recoveries

🌩️ Even a hurricane can't stop me

The United States Should Print $250 Billion & Buy Bitcoin

Let's Talk News Sites? (This One Makes $42K/Month)

Want 4 months of Litmus for free?

Microstrategy Buys $4.6B in Bitcoin as Saylor Speeds Up Accumulation

How to master executive brand advocacy on social

🦅 The data-driven strategy to grow on 𝕏 [Q4 2024]